Director, Clinical Research — RNAi Therapeutics Lead

Alnylam Pharmaceuticals is seeking an imaginative physician drug developer to lead clinical programs across neurology and hematology. The Director will provide clinical leadership in developing RNAi therapeutics and drive progress from Phase 2 to Phase 3, reporting to the program strategy lead and collaborating with regulatory, biostatistics, clinical operations, preclinical, and medical affairs teams.

The role emphasizes serving as a development spokesperson at external meetings and regulatory

#J-18808-Ljbffr